March 10 (Reuters) - Lifestance Health Group Inc LFST.O :
* LIFESTANCE REPORTS FOURTH QUARTER AND FULL YEAR 2021
RESULTS
* Q4 REVENUE $190.1 MILLION
* SEES Q1 REVENUE $195 MILLION TO $200 MILLION
* SEES FY REVENUE $865 MILLION TO $885 MILLION
* ESTIMATED REVENUE IMPACT FROM OMICRON IN THE RANGE OF $3
TO $7
MILLION IN THE FIRST QUARTER.
* Q4 REVENUE VIEW $191.7 MILLION -- REFINITIV IBES DATA
* Q1 REVENUE VIEW $205.0 MILLION -- REFINITIV IBES DATA
* FY2022 REVENUE VIEW $875.9 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX9p8Zy0
Further company coverage: LFST.O
((Reuters.Briefs@thomsonreuters.com;))